Research Paper Volume 15, Issue 24 pp 15535—15556
Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma
Figure 3. Comparative analysis of targets of immunomodulatory drugs in clinical trials for metastatic esophageal cancer between two clusters. The expression levels of immunomodulatory targets related to PD1 (A), CTLA4 (B), other immune checkpoint molecules (C), and agonists of T cell activation (D) varied between Cluster 1 and Cluster 2. *P < 0.05, **P < 0.01, ***P < 0.001.